Ionis Pharmaceuticals, Inc. has successfully priced an underwritten public offering of 11,500,000 common stock shares at $43.50 each, expecting approximately $500.3 million in gross proceeds.
The offering also includes an option for underwriters to purchase up to an additional 1,725,000 shares at the same public offering price, ensuring potential extra liquidity.
[
Collection
]
[
|
...
]